The Impact of Emerging Dolutegravir Resistance on Global HIV Treatment and Prevention
Today's Clinical Lab
Dr. Obiageli Okafor discusses growing resistance to dolutegravir and the need for global access to affordable HIV treatment and prevention
HIV Research
New HIV Panel Aims to Advance Virology Research
Integrated DNA Technologies
The new test panel provides a single-tube, 2.5-hour workflow designed to enable detection down to 1,000 viral genome copies
Blood Glycans May Accelerate Biological Aging in HIV Patients
The Wistar Institute
The findings shed light on how sugar molecules in the blood of people living with HIV may have pro-inflammatory effects
Current Tools Underestimate CVD Risk in People with HIV
National Institutes of Health
Trial reveals the need for more accurate screening in Black people and cisgender women
Building an Affordable and Immunogenic HIV Vaccine
Amsterdam University Medical Centers
This global project aims to discover an HIV vaccine that is practical for those in low-resource countries
Smallpox Vaccine Immunizes People with HIV against Mpox
Universitat Pompeu Fabra
Intradermally administering JYNNEOS vaccine induces an efficient immune response against mpox in people with HIV-1 infection
Cisgender Women Excluded in Pivotal STI Prevention Studies
National Institutes of Health
NIH leadership calls for population-specific considerations in study design
Understanding CD8+ T-Cell Activity May Augment HIV Vaccine Efficacy
National Institutes of Health
Study suggests greater CD8+ T-cell activity may increase HIV immunity
Targeting Viral Protein May Reduce HIV-Related Comorbidities
University of Montreal Hospital Research Centre
Per the WHO records, more than 39 million people were living with HIV at the end of 2022
HIV Vaccine Phase 1 Trial Begins in the US and South Africa
National Institutes of Health
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system